Half cell solar panels, which divide conventional full-sized cells into two electrically independent halves, have moved from ...

Fujiyama Power has announced plans to commission its 1GW solar cell manufacturing plant in Dadri, Uttar Pradesh.

Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

Management continues to anticipate the presentation of three-year OpRegen trial data in June 2025, with Culley expressing hope it will “provide additional conviction in our approach.” There remains no ...

Chinese solar manufacturer GCL Technologies has signed a deal to build a 5GW solar cell and module manufacturing facility in ...

"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...

SOUTH SAN FRANCISCO, Calif. & LONDON--(BUSINESS WIRE)--Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation ...

India's ambitious battery manufacturing scheme faces setbacks from visa delays, local production mandates, and technology shortages, report reveals.

Reliance Industries pauses its plans to manufacture lithium-ion cells in India amid challenges in securing technology ...

Jan 12 (Reuters) - India's Reliance Industries said on Monday that its plans for battery storage manufacturing remain ...

Reliance Industries has paused lithium-ion battery cell manufacturing plans in India after talks with a Chinese technology partner collapsed. The development comes as India joins G7-led discussions to ...